Explore / Clinical trial
Clinical trial

Immunomodulatory Properties of Ketamine in Sepsis

Beth Israel Deaconess Medical CenterCompletedPhase 1Started Dec 1, 200919 enrolledUnited StatesNCT01089361

Abstract

The aim of the study is to assess the effect of short-term infusion of ketamine at analgesic dosage on the immune response, morbidity and mortality among patients suffering from septic shock. We hypothesize that ketamine will modulate the cytokine response to sepsis and reduce morbidity and mortality.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

Ketamine

Keywords

systemic inflammatory syndromesepsis syndromeseptic shockCytokineSepsis

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.